CINVANTI
NDC 47426-201 · Heron Therapeutics, Inc.
Generic nameaprepitant
Dosage formINJECTION, EMULSION
RouteINTRAVENOUS
Active ingredient(s)APREPITANT
Strength130 mg/18mL
Pharmacologic classCytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]
Marketing categoryNDA
Packages
47426-201-01 — 1 VIAL, GLASS in 1 CARTON (47426-201-01) / 18 mL in 1 VIAL, GLASS
Billed under HCPCS
J0185 — Injection, aprepitant, 1 mg Medicare Part B payment limit (ASP + 6%): $1.59
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0006-0461 — aprepitant, 0006-0462 — aprepitant, 0006-0464 — aprepitant, 0006-3066 — aprepitant, 0781-2321 — aprepitant, 0781-2322 — aprepitant, 0781-2323 — aprepitant, 13668-591 — APREPITANT, 13668-592 — APREPITANT, 13668-593 — APREPITANT, 47426-401 — APREPITANT, 51407-701 — APREPITANT, 51407-702 — APREPITANT, 51407-703 — APREPITANT, 68001-666 — Aprepitant, 68001-667 — Aprepitant, 68001-668 — Aprepitant, 68462-583 — Aprepitant, 68462-584 — Aprepitant, 68462-585 — Aprepitant